Report cover image

South & Central America Acute Pancreatitis Market Forecast to 2030 – Regional Analysis – by Offerings (Medications, Diagnosis, and Others), Causes (Gallstones, Alcoholism, Genetic Disorders, Infection, and Others), and End User (Hospitals, Diagnostic Labo

Publisher The Insight Partners
Published Jan 03, 2024
Length 93 Pages
SKU # TIP18628154

Description

South & Central America Acute Pancreatitis Market Forecast to 2030 – Regional Analysis – by Offerings (Medications, Diagnosis, and Others), Causes (Gallstones, Alcoholism, Genetic Disorders, Infection, and Others), and End User (Hospitals, Diagnostic Laboratories, Ambulatory Surgical Centers, and Others)The South & Central America acute pancreatitis market was valued at US$ 209.04 million in 2022 and is expected to reach US$ 333.67 million by 2030; it is estimated to grow at a CAGR of 6.0% from 2022 to 2030.

Upsurge in Number of R&D Activities and Awareness Programs on Acute Pancreatitis Fuels the South & Central America Acute Pancreatitis Market

Extensive research studies are being conducted globally to investigate the etiology, progress, and treatment of acute pancreatitis. The National Pancreas Foundation (NPF) provides multiple research grants worth ~US$ 50,000 per project. To date, the NPF has provided more than US$ 5 million for 133 ground-breaking research projects. A grant is awarded for a period of a year to diagnose and/or treat pancreatitis, pancreatic cancer, or pediatric pancreatitis.

Further, several ongoing international efforts are being made to define the epidemiology and pathophysiology of acute pancreatitis. The National Institute for Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health (NIH), formed a collaborative network of 10 clinical centers and 1 data coordination center in 2020 to address several knowledge gaps regarding acute pancreatitis. The consortium is referred to as Type 1 Diabetes after Acute Pancreatitis Consortium (T1DAPC). Thus, R&D activities and awareness programs on acute pancreatitis for the development of effective therapies (through direct and indirect means) are expected to be highly fruitful for companies in the South & Central America acute pancreatitis market.

South & Central America Acute Pancreatitis Market Overview

The South & Central America acute pancreatitis market is segmented into Brazil, Argentina, and the Rest of South & Central America. Increasing in geriatric population in the region and increase in cases of acute pancreatitis is fueling the growth of the South & Central America acute pancreatitis market in the region. Acute pancreatitis is a life-threatening disease, especially in the geriatric population due to co-morbidities and compromised body systems. As per Brazil's Ministry of Health, by 2030, Brazil is anticipated to rank fifth in terms of geriatric population worldwide. The WHO estimated that the elderly population will have increased by more than 300% and the overall population will grow by 30% by 2050 in the country. According to Pan American Health Organization (PAHO), in 2022, Brazil had more than 30 million people aged above 60, which represents 30% of the total population. The number of people aged above 60 is expected to reach ~50 million, which is expected to represent 24% of the total population of Brazil by 2050. Apart from aging, alcohol consumption can also cause acute pancreatitis. According to an article published in Nature, 85.2% of the total alcohol drinkers were heavy drinkers in Brazil. Thus, the increase in alcohol consumption in Brazil is also fueling the growth of the South & Central America acute pancreatitis market.

South & Central America Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)

South & Central America Acute Pancreatitis Market Segmentation

The South & Central America acute pancreatitis market is segmented offerings, causes, end user, and country.

Based on offerings, the South & Central America acute pancreatitis market is segmented into medications, diagnosis, and others. The diagnosis segment held the largest market share in 2022.

Based on causes, the South & Central America acute pancreatitis market is segmented into gallstones, alcoholism, genetic disorders, infection, and others. The gallstones segment held the largest market share in 2022.

Based on end user, the South & Central America acute pancreatitis market is divided into hospitals, diagnostic laboratories, ambulatory surgical centres, and others. The hospitals segment held the largest market share in 2022.

Based on country, the South & Central America acute pancreatitis market is segmented into Brazil, Argentina, and the Rest of South & Central America. The Rest of South & Central America dominated the South & Central America acute pancreatitis market share in 2022.

Abbott Laboratories, Baxter International Inc, Boston Scientific Corp, Fresenius Kabi AG, GE HealthCare Technologies Inc, Koninklijke Philips NV, Medtronic Plc, and Samsung Healthcare are some of the leading companies operating in the South & Central America acute pancreatitis market.

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the South & Central America acute pancreatitis market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in South & Central America acute pancreatitis market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth South & Central America market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Table of Contents

93 Pages
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
2.2 South & Central America Acute Pancreatitis Market, by Country (US$ Million)
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. South & Central America Acute Pancreatitis Market Landscape
4.1 Overview
5. South & Central America Acute Pancreatitis Market - Key Industry Dynamics
5.1 Key Market Drivers
5.1.1 Rise in Pancreatic Cancer Cases Due to Acute Pancreatitis
5.1.2 Rising Incidence of Diabetes Following Acute Pancreatitis
5.2 Key Market Restraints
5.2.1 Side Effects of Pancreatitis and Pancreatic Cancer Treatments
5.3 Key Market Opportunities
5.3.1 Upsurge in Number of R&D Activities and Awareness Programs on Acute Pancreatitis
5.4 Future Trends
5.4.1 Advancements in Specific Acute Pancreatitis Treatments
5.5 Impact Analysis:
6. Acute Pancreatitis Market - South & Central America Market Analysis
6.1 South & Central America Acute Pancreatitis Market Revenue (US$ Mn), 2022 – 2030
7. South & Central America Acute Pancreatitis Market – Revenue and Forecast to 2030 – by Offerings
7.1 Overview
7.2 South & Central America Acute Pancreatitis Market Revenue Share, by Offerings, 2022 & 2030 (%)
7.3 Medications
7.3.1 Overview
7.3.2 Medications: South & Central America Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
7.3.2.1 South & Central America Acute Pancreatitis Market, by Medications, 2020–2030 (US$ Million)
7.4 Diagnosis
7.4.1 Overview
7.4.2 Diagnosis: South & Central America Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
7.4.2.1 South & Central America Acute Pancreatitis Market, by Diagnosis, 2020–2030 (US$ Million)
7.5 Others
7.5.1 Overview
7.5.2 Others: South & Central America Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
8. South & Central America Acute Pancreatitis Market – Revenue and Forecast to 2030 – by Causes
8.1 Overview
8.2 South & Central America Acute Pancreatitis Market Revenue Share, by Causes 2022 & 2030 (%)
8.3 Gallstones
8.3.1 Overview
8.3.2 Gallstones: South & Central America Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Alcoholism
8.4.1 Overview
8.4.2 Alcoholism: South & Central America Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
8.5 Genetic Disorders
8.5.1 Overview
8.5.2 Genetic Disorders: South & Central America Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
8.6 Infections
8.6.1 Overview
8.6.2 Infections: South & Central America Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
8.7 Others
8.7.1 Overview
8.7.2 Others: South & Central America Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
9. South & Central America Acute Pancreatitis Market – Revenue and Forecast to 2030 – by End User
9.1 Overview
9.2 South & Central America Acute Pancreatitis Market Revenue Share, by End User, 2022 & 2030 (%)
9.3 Hospitals
9.3.1 Overview
9.3.2 Hospitals: South & Central America Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
9.4 Diagnostic Laboratories
9.4.1 Overview
9.4.2 Diagnostic Laboratories: South & Central America Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
9.5 Ambulatory Surgical Centers
9.5.1 Overview
9.5.2 Ambulatory Surgical Centers: South & Central America Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: South & Central America Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
10. South & Central America Acute Pancreatitis Market - Country Analysis
10.1 Overview
10.1.1.1 South & Central America Acute Pancreatitis Market, by Country
10.1.1.2 Brazil
10.1.1.2.1 Overview
10.1.1.2.2 Brazil: South & Central America Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.2.3 Brazil: South & Central America Acute Pancreatitis Market, by Offerings, 2020–2030 (US$ Million)
10.1.1.2.3.1 Brazil: South & Central America Acute Pancreatitis Market, For Medications by Offerings, 2020–2030 (US$ Million)
10.1.1.2.3.2 Brazil: South & Central America Acute Pancreatitis Market, For Diagnosis by Offerings, 2020–2030 (US$ Million)
10.1.1.2.4 Brazil: South & Central America Acute Pancreatitis Market, by Causes, 2020–2030 (US$ Million)
10.1.1.2.5 Brazil: South & Central America Acute Pancreatitis Market, by End User, 2020–2030 (US$ Million)
10.1.1.3 Argentina
10.1.1.3.1 Overview
10.1.1.3.2 Argentina: South & Central America Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.3.3 Argentina: South & Central America Acute Pancreatitis Market, by Offerings, 2020–2030 (US$ Million)
10.1.1.3.3.1 Argentina: South & Central America Acute Pancreatitis Market, For Medications by Offerings, 2020–2030 (US$ Million)
10.1.1.3.3.2 Argentina: South & Central America Acute Pancreatitis Market, For Diagnosis by Offerings, 2020–2030 (US$ Million)
10.1.1.3.4 Argentina: South & Central America Acute Pancreatitis Market, by Causes, 2020–2030 (US$ Million)
10.1.1.3.5 Argentina: South & Central America Acute Pancreatitis Market, by End User, 2020–2030 (US$ Million)
10.1.1.4 Rest of South & Central America
10.1.1.4.1 Overview
10.1.1.4.2 Rest of South & Central America: South & Central America Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.4.3 Rest of South & Central America: South & Central America Acute Pancreatitis Market, by Offerings, 2020–2030 (US$ Million)
10.1.1.4.3.1 Rest of South & Central America: South & Central America Acute Pancreatitis Market, For Medications by Offerings, 2020–2030 (US$ Million)
10.1.1.4.3.2 Rest of South & Central America: South & Central America Acute Pancreatitis Market, For Diagnosis by Offerings, 2020–2030 (US$ Million)
10.1.1.4.4 Rest of South & Central America: South & Central America Acute Pancreatitis Market, by Causes, 2020–2030 (US$ Million)
10.1.1.4.5 Rest of South & Central America: South & Central America Acute Pancreatitis Market, by End User, 2020–2030 (US$ Million)
11. South & Central America Acute Pancreatitis Market–Industry Landscape
11.1 Overview
11.2 Growth Strategies in the South & Central America Acute Pancreatitis Market
11.3 Inorganic Growth Strategies
11.3.1 Overview
11.4 Organic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1 Abbott Laboratories
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 GE HealthCare Technologies Inc
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Samsung Healthcare
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Koninklijke Philips NV
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Baxter International Inc
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Medtronic Plc
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Boston Scientific Corp
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Fresenius Kabi AG
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
13. Appendix
13.1 About Us
13.2 Glossary of Terms
LIST OF TABLES
Table 1. South & Central America Acute Pancreatitis Market Segmentation
Table 2. South & Central America Acute Pancreatitis Market, by Medications – Revenue and Forecast to 2030 (US$ Million)
Table 3. South & Central America Acute Pancreatitis Market, by Diagnosis – Revenue and Forecast to 2030 (US$ Million)
Table 4. Brazil: South & Central America Acute Pancreatitis Market, by Offerings – Revenue and Forecast to 2030 (US$ Million)
Table 5. Brazil: South & Central America Acute Pancreatitis Market, For Medications by Offerings – Revenue and Forecast to 2030 (US$ Million)
Table 6. Brazil: South & Central America Acute Pancreatitis Market, For Diagnosis by Offerings – Revenue and Forecast to 2030 (US$ Million)
Table 7. Brazil: South & Central America Acute Pancreatitis Market, by Causes – Revenue and Forecast to 2030 (US$ Million)
Table 8. Brazil: South & Central America Acute Pancreatitis Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 9. Argentina: South & Central America Acute Pancreatitis Market, by Offerings – Revenue and Forecast to 2030 (US$ Million)
Table 10. Argentina: South & Central America Acute Pancreatitis Market, For Medications by Offerings – Revenue and Forecast to 2030 (US$ Million)
Table 11. Argentina: South & Central America Acute Pancreatitis Market, For Diagnosis by Offerings – Revenue and Forecast to 2030 (US$ Million)
Table 12. Argentina: South & Central America Acute Pancreatitis Market, by Causes – Revenue and Forecast to 2030 (US$ Million)
Table 13. Argentina: South & Central America Acute Pancreatitis Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 14. Rest of South & Central America: South & Central America Acute Pancreatitis Market, by Offerings – Revenue and Forecast to 2030 (US$ Million)
Table 15. Rest of South & Central America: South & Central America Acute Pancreatitis Market, For Medications by Offerings – Revenue and Forecast to 2030 (US$ Million)
Table 16. Rest of South & Central America: South & Central America Acute Pancreatitis Market, For Diagnosis by Offerings – Revenue and Forecast to 2030 (US$ Million)
Table 17. Rest of South & Central America: South & Central America Acute Pancreatitis Market, by Causes – Revenue and Forecast to 2030 (US$ Million)
Table 18. Rest of South & Central America: South & Central America Acute Pancreatitis Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 19. Recent Inorganic Growth Strategies in the South & Central America Acute Pancreatitis Market
Table 20. Recent Organic Growth Strategies in the South & Central America Acute Pancreatitis Market
Table 21. Glossary of Terms, South & Central America Acute Pancreatitis Market
LIST OF FIGURES
Figure 1. South & Central America Acute Pancreatitis Market Segmentation, By Country
Figure 2. South & Central America Acute Pancreatitis Market - Key Industry Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. South & Central America Acute Pancreatitis Market Revenue (US$ Mn), 2022 – 2030
Figure 5. South & Central America Acute Pancreatitis Market Revenue Share, by Offerings, 2022 & 2030 (%)
Figure 6. Medications: South & Central America Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
Figure 7. Diagnosis: South & Central America Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
Figure 8. Others: South & Central America Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
Figure 9. South & Central America Acute Pancreatitis Market Revenue Share, by Causes 2022 & 2030 (%)
Figure 10. Gallstones: South & Central America Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
Figure 11. Alcoholism: South & Central America Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
Figure 12. Genetic Disorders: South & Central America Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
Figure 13. Infections: South & Central America Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
Figure 14. Others: South & Central America Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
Figure 15. South & Central America Acute Pancreatitis Market Revenue Share, by End User, 2022 & 2030 (%)
Figure 16. Hospitals: South & Central America Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
Figure 17. Diagnostic Laboratories: South & Central America Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
Figure 18. Ambulatory Surgical Centers: South & Central America Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
Figure 19. Others: South & Central America Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
Figure 20. South & Central America Acute Pancreatitis Market, by Key Country – Revenue, 2022 (US$ Million)
Figure 21. South & Central America Acute Pancreatitis Market, By Key Countries, 2022 and 2030 (%)
Figure 22. Brazil: South & Central America Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
Figure 23. Argentina: South & Central America Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
Figure 24. Rest of South & Central America: South & Central America Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
Figure 25. Growth Strategies in the South & Central America Acute Pancreatitis Market

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us